McBroom & Associates’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24M Sell
55,403
-8,009
-13% -$2.43M 12.07% 1
2026
Q1
$13.5M Sell
63,412
-19,207
-23% -$4.29M 7.55% 2
2025
Q4
$14.1M Sell
82,619
-2,955
-3% -$460K 6.87% 2
2025
Q3
$11.5M Sell
85,574
-3,721
-4% -$394K 5.45% 4
2025
Q2
$6.49M Hold
89,295
3.71% 13
2025
Q1
$6.49M Buy
89,295
+1,743
+2% +$137K 3.71% 13
2024
Q4
$6.32M Buy
+87,552
New +$6.64M 3.58% 15
2024
Q3
Sell
-85,940
Closed -$9.15M 35
2024
Q2
$9.15M Buy
85,940
+590
+0.7% +$56.6K 5.73% 4
2024
Q1
$8.29M Sell
85,350
-7,120
-8% -$626K 5.46% 6
2023
Q4
$7.24M Sell
92,470
-160
-0.2% -$10.9K 5.28% 6
2023
Q3
$5.81M Buy
92,630
+1,630
+2% +$107K 4.62% 7
2023
Q2
$5.85M Buy
91,000
+2,340
+3% +$132K 4.62% 8
2023
Q1
$4.7M Buy
88,660
+7,350
+9% +$361K 4.2% 9
2022
Q4
$3.42M Sell
81,310
-2,180
-3% -$91.2K 3.71% 14
2022
Q3
$3.06M Sell
83,490
-3,160
-4% -$141K 3.45% 15
2022
Q2
$3.69M Sell
86,650
-2,810
-3% -$134K 4.02% 14
2022
Q1
$4.81M Sell
89,460
-2,800
-3% -$163K 4.26% 15
2021
Q4
$6.63M Buy
+92,260
New +$5.78M 4.99% 10

Other funds holding LRCX

McBroom & Associates's LRCX Position: Q2 2026 in Review

McBroom & Associates reduced its Lam Research (LRCX) stake by 13% in Q2 2026, selling an estimated $2.43M and leaving 55,403 shares worth $24M. The position accounts for 12.07% of the portfolio, ranked #1.

McBroom & Associates first reported a position in LRCX in Q4 2021 and has held it in 18 quarters since. 1,427 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • McBroom & Associates held 55,403 shares of Lam Research worth $24M as of Q2 2026.
  • McBroom & Associates sold 8,009 Lam Research shares in Q2 2026, an estimated $2.43M.
  • Lam Research made up 12.07% of McBroom & Associates's portfolio in Q2 2026, its #1 holding.
  • McBroom & Associates first reported a position in Lam Research in Q4 2021 and has held it in 18 quarters since.
  • 1,427 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on McBroom & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.